Council for Innovation Promotion

Fact Check: Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices

Claim: On December 7, the Biden administration proposed a policy framework claiming a newfound authority, under the 43-year-old Bayh-Dole Act, to rescind patent licenses on drugs, energy, climate change, and all other inventions that benefit from federal research funding based on the price of the resulting product. The administration asserts that this framework is an

Fact Check: Misusing the Bayh-Dole Act’s March-In Rights is Not an Effective Way to Reduce Drug Prices Read More »

New Op-Ed from C4IP Board: Europe Stands at a Crossroads on Technology Policy

Yesterday, the C4IP Board published an opinion piece in Euractiv highlighting how the European Commission’s recent proposal for standard-essential patents (SEPs) has empowered China to unilaterally set its own licensing terms, jeopardizing a longstanding model of international cooperation and threatening Europe’s own leadership in wireless technology. In the piece, the board explains how SEPs —

New Op-Ed from C4IP Board: Europe Stands at a Crossroads on Technology Policy Read More »

Celebrating American Innovation: Ashok Gadgil

C4IP is highlighting the accomplishments of Ashok Gadgil from the University of California, Berkeley. His groundbreaking invention, utilizing ultraviolet light to purify water, was brought to market pursuant to the Bayh-Dole Act and has since saved millions of lives across the globe. Ashok Gadgil was born in Mumbai, India, in 1950. He attended the University

Celebrating American Innovation: Ashok Gadgil Read More »

Scroll to Top